New suPARnostic® Distributor in Serbia

Wed Feb 21 2018

We warmly welcome Alura Med. as the new distributor of suPARnostic® in Serbia. This partnership is a significant step towards providing advanced medical solutions to Serbian healthcare. With Alura Med.’s expertise, we’re confident that suPARnostic® will reach more professionals and patients, advancing medical diagnostics.

Alura Med.’s dedication to quality aligns with our mission. suPARnostic®, an innovative biomarker test, offers insights for disease assessment and prognosis. Supported by Alura Med.’s distribution network, we empower Serbian healthcare with tools for better patient care.

This collaboration makes suPARnostic® accessible in Serbia, enabling early detection and informed interventions for improved outcomes. With Alura Med., we anticipate enhancing diagnostics and contributing to better healthcare in Serbia.

Please find contact details here:

Alura med.
Resavska 78b
11000 Belgrade
Serbia

Contact: Katarina Djordjevic
Phone: +381 64 64 32 449
E-mail: office@aluramed.com
Website:www.aluramed.com

Serbia

900+

published suPAR studies in leading medical journals

Nature Medicine Logo
Science Journal Logo
JAMA Pediatrics Logo

The suPARnostic® brand consists of 4 products:

Quick Triage

A Point of Care Solution

TurbiLatex

For Automated Systems

ELISA Assay

Clinical and Research

suPARnostic POC+

POC+

Point-of-care finger prick

suPAR is used in clinical routine in 48 hospitals

48 hospitals use suPAR in clinical routine for triage of patients in the Emergency Departments and COVID-19 units. Clinical routine is defined by the placement of two Purchasing Orders within the last 12 months rolling.
This period covers January 1, 2022, until December 31, 2022. Some hospital locations cannot be disclosed due to confidentiality.

New Webinar

Webinar

Catch COVID-19

-Improve your triage

Sign up to view webinar recording

View recording

suPARnostic® by ViroGates